Head-to-head comparisons of medication uses, side effects, warnings, and more.
Key takeaways
Phentermine (Adipex-P) and semaglutide (Ozempic) are both medications used to help with weight management, but they belong to different drug classes and have important differences. Phentermine is a sympathomimetic stimulant primarily used for short-term weight loss in adults with a high body mass index (BMI), while semaglutide is a glucagon-like peptide-1 (GLP-1) agonist used to treat Type 2 diabetes and reduce the risk of heart problems in adults with diabetes. Ozempic is sometimes used off-label for weight loss. Phentermine is taken orally, usually once a day, and is available in various forms, including tablets and capsules. In contrast, semaglutide is an injection used under the skin once a week. Phentermine is a controlled substance due to its potential for misuse and dependence, whereas semaglutide is not. Common side effects of phentermine include dry mouth and trouble sleeping, while semaglutide often causes nausea and diarrhea. Additionally, phentermine is available as a lower-cost generic, whereas semaglutide is only available as a brand-name medication.
Phentermine (Adipex-P)
Ozempic (semaglutide)
Phentermine (Adipex-P)
Ozempic (semaglutide)
Summary of Phentermine vs. Ozempic
Summary for Sympathomimetic
Prescription only
Phentermine (Adipex-P) is an appetite suppressant. It's a prescription weight loss pill for people ages 17 years and older. This medication works best when it's part of a treatment plan that involves healthy diet and regular exercise. Phentermine (Adipex-P) is taken by mouth once daily, typically in the morning. Some of the more common side effects of this medication include dry mouth, trouble sleeping, and headache.
Summary for GLP-1 agonist
Prescription only
Ozempic (semaglutide) is a prescription injection used with diet and exercise to help manage Type 2 diabetes in adults. It's also FDA approved to lower the risk of heart attack, stroke, and heart-related death in those with Type 2 diabetes and heart disease. In addition, it can reduce the risk of worsening kidney problems in people with Type 2 diabetes and chronic kidney disease (CKD). Ozempic (semaglutide) is a GLP-1 agonist that's injected under the skin once a week. Common side effects include nausea, vomiting, and diarrhea.